Judith Alberto: COA Takes on Congress, Addresses Change Healthcare Cyberattack
April 18th 2024Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives at the Community Oncology Alliance (COA), discusses upcoming policy initiatives and the current oncology landscape amid a health care cyberattack.
Read More
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Dr Mila Felder Shares Targeted Education Approaches to Promote Well-Being
April 17th 2024Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, highlights strategic approaches for incorporating well-being into a postpandemic oncology workforce.
Read More
Dr Lawrence Eichenfield Hopeful for New Pediatric AD Treatment Option
April 16th 2024Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital in San Diego, shared the implications of the findings from INTEGUMENT-PED, the phase 3 study assessing the efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients with atopic dermatitis (AD), for future clinical practice.
Read More
Will Shapiro Shares How Artificial Intelligence Is Benefiting Oncology Care
April 15th 2024Will Shapiro, vice president of data science at Flatiron Health, discusses how the practice is using large language models (LLMs) to increase efficiency, while ensuring there are frameworks set for safety and quality.
Read More
Dr Joseph Zabinski Discusses Challenges in Identifying Patients With GPP
April 11th 2024Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1, addresses challenges in identifying patients with generalized pustular psoriasis (GPP) and how artificial intelligence (AI) can help alleviate these concerns.
Read More
Dr Mila Felder Explains the Benefits of a Well-Being Council in Oncology Practices
April 11th 2024Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, shares the importance of incorporating a culture of well-being within oncology practices.
Read More
Dr Robert Sidbury on Implementing Value-Based Care Initiatives in a Pediatric Dermatology Practice
April 9th 2024Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine, discusses implementing value-based care initiatives in a pediatric dermatology practice.
Read More
Dr Mila Felder Discusses How Peer Support Programs Can Help Alleviate Drug Shortage Distress
April 8th 2024Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, shares insights on how peer support groups can help manage psychological and emotional distress amid a national drug shortage.
Read More
Will Shapiro Discusses Ethical Challenges Across Various Artificial Intelligence Models in Oncology
April 5th 2024Will Shapiro, vice president of data science at Flatiron Health, explains the different ethical challenges associated with various forms of artificial intelligence models used in oncology care.
Read More
Dr Joseph Zabinski Discusses Using Artificial Intelligence to Identify Patients With GPP
April 4th 2024Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1, discusses ways that AI is being integrated into personalized medicine for patients with generalized pustular psoriasis (GPP).
Read More
Dr Mila Felder Discusses Peer-to-Peer Support in Health Care Organizations
April 4th 2024Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health, discusses the impact of peer support groups within a health care organization and its patients.
Read More
Dr Jonathan Silverberg Describes AD Diagnosis, Treatment in Children vs Adults
April 2nd 2024Jonathan Silverberg, MD, PhD, MPH, FAAD, of George Washington University School of Medicine and Health Sciences, discusses atopic dermatitis (AD) diagnosis and treatment differences in children vs adults.
Read More
Dr Raj Chovatiya Explains Oral JAK Inhibitor Monitoring Protocols for AD Treatment
April 1st 2024Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University of Medicine and Science, described monitoring protocols for clinicians when using oral Janus kinase (JAK) inhibitors to treat patients with atopic dermatitis (AD).
Read More
Dr Jeff Stark: Bimekizumab Shows Long-Term Efficacy When Used to Treat Patients With HS
April 1st 2024Despite the positive week 48 results when used to treat moderate to severe hidradenitis suppurativa (HS), Jeff Stark, MD, of Union Chimique Belge, noted that bimekizumab is still considered an investigational therapy for HS treatment as it has not yet received an FDA approval.
Read More